相似文献
1
Pharmacogenomics of preterm birth prevention and treatment.
BJOG. 2016 Feb;123(3):368-75. doi: 10.1111/1471-0528.13744. Epub 2015 Nov 6.
2
Genetic factors in preterm birth--the future.
BJOG. 2005 Mar;112 Suppl 1:97-102. doi: 10.1111/j.1471-0528.2005.00595.x.
3
Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
Am J Perinatol. 2008 Oct;25(9):555-60. doi: 10.1055/s-0028-1085622. Epub 2008 Sep 4.
4
Myth: tocolysis for prevention of preterm birth has a major role in modern obstetrics.
Semin Fetal Neonatal Med. 2011 Oct;16(5):242-6. doi: 10.1016/j.siny.2011.04.008.
5
The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Aust N Z J Obstet Gynaecol. 2014 Jun;54(3):231-6. doi: 10.1111/ajo.12179. Epub 2014 Feb 8.
6
Prematurity prevention: the role of acute tocolysis.
Curr Opin Obstet Gynecol. 2009 Apr;21(2):136-41. doi: 10.1097/GCO.0b013e3283292455.
7
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
BJOG. 2015 Jan;122(1):80-91. doi: 10.1111/1471-0528.13061. Epub 2014 Sep 11.
8
Comparison of nifedipine and progesterone for maintenance tocolysis after arrested preterm labour.
J Obstet Gynaecol. 2014 May;34(4):322-5. doi: 10.3109/01443615.2013.874407. Epub 2014 Jan 31.
9
Preterm labour: association between labour physiology, tocolysis and prevention.
Expert Opin Investig Drugs. 2014 Jun;23(6):759-71. doi: 10.1517/13543784.2014.905541. Epub 2014 Apr 9.
10
Contemporary practice patterns and beliefs regarding tocolysis among u.s. Maternal-fetal medicine specialists.
Obstet Gynecol. 2008 Jul;112(1):42-7. doi: 10.1097/AOG.0b013e318176158e.
引用本文的文献
1
Unravelling the genetic landscape of cervical insufficiency: Insights into connective tissue dysfunction and hormonal pathways.
PLoS One. 2024 Sep 19;19(9):e0310718. doi: 10.1371/journal.pone.0310718. eCollection 2024.
2
Antenatal Late Preterm Steroids: The Evolution of the ALPS Trial.
Clin Obstet Gynecol. 2024 Jun 1;67(2):399-410. doi: 10.1097/GRF.0000000000000865. Epub 2024 Apr 29.
3
What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.
Am J Obstet Gynecol MFM. 2023 Oct;5(10):101108. doi: 10.1016/j.ajogmf.2023.101108. Epub 2023 Jul 30.
4
Effect of dydrogesterone and progesterone on threatened miscarriage due to corpus luteum insufficiency.
Am J Transl Res. 2021 May 15;13(5):4544-4552. eCollection 2021.
5
Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges.
Pharmgenomics Pers Med. 2019 Oct 14;12:273-285. doi: 10.2147/PGPM.S179172. eCollection 2019.
6
Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility.
Croat Med J. 2017 Apr 14;58(2):96-104. doi: 10.3325/cmj.2017.58.96.
7
Refining Pharmacologic Research to Prevent and Treat Spontaneous Preterm Birth.
Front Pharmacol. 2017 Mar 15;8:118. doi: 10.3389/fphar.2017.00118. eCollection 2017.
8
Prenatal pharmacogenomics: a promising area for research.
Pharmacogenomics J. 2016 Aug;16(4):303-4. doi: 10.1038/tpj.2016.33. Epub 2016 May 10.
本文引用的文献
1
Effects of β2-adrenergic receptor gene polymorphisms on ritodrine therapy in pregnant women with preterm labor: prospective follow-up study.
Int J Mol Sci. 2014 Jul 21;15(7):12885-94. doi: 10.3390/ijms150712885.
2
Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins.
Pharmacogenomics. 2014 May;15(7):1029-41. doi: 10.2217/pgs.14.62.
3
Correlation between initial neonatal and early childhood outcomes following preterm birth.
Am J Obstet Gynecol. 2014 May;210(5):426.e1-9. doi: 10.1016/j.ajog.2014.01.046.
4
Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.
Am J Obstet Gynecol. 2014 Apr;210(4):321.e1-321.e21. doi: 10.1016/j.ajog.2014.01.013. Epub 2014 Mar 1.
5
Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy.
Clin Pharmacokinet. 2014 Apr;53(4):373-83. doi: 10.1007/s40262-013-0123-0.
6
Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions.
BMC Med. 2013 Nov 7;11:237. doi: 10.1186/1741-7015-11-237.
7
Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age.
Front Cell Neurosci. 2013 Oct 11;7:180. doi: 10.3389/fncel.2013.00180. eCollection 2013.
8
Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.
Am J Obstet Gynecol. 2014 Feb;210(2):128.e1-6. doi: 10.1016/j.ajog.2013.10.008. Epub 2013 Oct 7.
9
Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.
Eur J Clin Pharmacol. 2013 Dec;69(12):1985-96. doi: 10.1007/s00228-013-1563-z. Epub 2013 Aug 17.
10
Transdermal nitroglycerin for the treatment of preterm labor: a systematic review and metaanalysis.
Am J Obstet Gynecol. 2013 Dec;209(6):551.e1-551.e18. doi: 10.1016/j.ajog.2013.07.022. Epub 2013 Jul 24.
Zotero 插件